All posts by: Michael Zand

About Michael Zand

Bioengineering Team’s ‘Circuit’ Work May Benefit Gene Therapy – University of Texas at Dallas (press release)

Continue reading

2018-02-28 NEWS

University of Texas at Dallas (press release)

Bioengineering Team’s ‘Circuit’ Work May Benefit Gene Therapy
University of Texas at Dallas (press release)
Synthetic biology is important for gene therapy applications, and our methodology may assist in building more robust and reliable therapeutics in the future,” Bleris said. The study was funded by the National Science Foundation. Other UT Dallas

Continue reading

2018-02-28 NEWS

Bioengineering Team’s ‘Circuit’ Work May Benefit Gene Therapy
University of Texas at Dallas (press release)
Synthetic biology is important for gene therapy applications, and our methodology may assist in building more robust and reliable therapeutics in the future,” Bleris said. The study was funded by the National Science Foundation. Other UT Dallas

Continue reading

2018-02-28 NEWS

UNC Lineberger researchers identify molecular target for brain cancer that could control tumor growth and lead to …
UNC News
The study is part of a research program launched at UNC Lineberger to develop personalized immune-based treatments called chimeric antigen receptor T cell, or CAR-T, therapies. This approach involves removing a patient’s immune cells and genetically

and more »

Continue reading

2018-02-28 NEWS

Medical Xpress

Researchers find new target on lethal brain tumor that can be hunted by immune cells
Medical Xpress
The study is part of a research program launched at UNC Lineberger to develop personalized immune-based treatments called chimeric antigen receptor T cell, or CAR-T, therapies. This approach involves removing a patient’s immune cells and genetically
Researchers Identify Molecular Target for Brain Cancer, Develop …Newswise (press release)

all 2 news articles »